How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

FDA Adds Warning Label to Weight-Loss Drugs for Eye Condition

calendar_today November 9, 2026 person Bloomberg domain the-business-of-fashion

The agency will now require drug companies making GLP-1 receptor agonist therapies to add safety labels warning that they could cause non-arteritic anterior ischemic optic neuropathy, or NAION.

open_in_new Read original post